LYTIR

Insider · SEC Form 4 · Director, 10% Owner

BAKER BROS. ADVISORS LP

In the 12 months to Nov 19, 2026, on the open market: bought $216.4M of KOD, MDGL; sold $317.8M of CELC. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $216.4M in total; Insider sales: $317.8M in total.Jul: Insider sales $317.8MSep: Insider purchases $157.0MNov: Insider purchases $59.4MDecJanFebMarAprMayJunJulAugSepOctNov$157.0M$317.8M
Insider purchases above the line: $216.4MInsider sales below: $317.8M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. MDGLBought: MADRIGAL PHARMACEUTICALS, INC. Nov 6, 2026 76,140 shares filed Nov 6, 2026 3 transactions filing $29.3M
  2. KODBought: Kodiak Sciences Inc. Nov 5, 2026 86,432 shares filed Nov 6, 2026 2 transactions filing $8.5M
  3. KODBought: Kodiak Sciences Inc. Nov 4, 2026 160,658 shares filed Nov 6, 2026 2 transactions filing $15.8M
  4. MDGLBought: MADRIGAL PHARMACEUTICALS, INC. Nov 4, 2026 15,666 shares filed Nov 6, 2026 2 transactions filing $5.8M
  5. KODBought: Kodiak Sciences Inc. Sep 29, 2026 33,726 shares filed Sep 30, 2026 6 transactions filing $2.9M
  6. KODBought: Kodiak Sciences Inc. Sep 28, 2026 1,908,029 shares filed Sep 30, 2026 76 transactions filing $154.1M
  7. CELCSold: Celcuity Inc. Jul 14, 2026 3,100,000 shares filed Jul 16, 2026 2 transactions filing $317.8M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Stakes filed (13D/13G)

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G

  1. MDGLBaker Bros. Advisors LP filed Nov 6, 2026 Schedule 13D/A may seek influence 2,330,144 shares issuer: Madrigal Pharmaceuticals, Inc. filing 9.99%
  2. KODBaker Bros. Advisors LP filed Sep 30, 2026 Schedule 13D/A may seek influence 22,049,297 shares issuer: Kodiak Sciences Inc. filing 35%
  3. ONCBaker Bros. Advisors LP filed Sep 16, 2026 Schedule 13D/A may seek influence 115,457,154 shares issuer: BeOne Medicines Ltd. filing 7.8%
  4. IMTXBaker Bros. Advisors LP filed Aug 14, 2026 Schedule 13G/A passive issuer: Immatics N.V. filing 7%
  5. RVMDBaker Bros. Advisors LP filed Aug 14, 2026 Schedule 13G passive issuer: Revolution Medicines, Inc. filing 5.3%
  6. IDYABaker Bros. Advisors LP filed Aug 14, 2026 Schedule 13G passive issuer: IDEAYA Biosciences, Inc. filing 5.2%
  7. EWTXBaker Bros. Advisors LP filed Aug 14, 2026 Schedule 13G/A passive issuer: Edgewise Therapeutics, Inc. filing 3.4%
  8. CERSBaker Bros. Advisors LP filed Aug 14, 2026 Schedule 13G/A passive issuer: Cerus Corporation filing 3.2%
  9. REPLBAKER BROS. ADVISORS LP filed Aug 11, 2026 Schedule 13D/A may seek influence 11,075,336 shares issuer: Replimune Group, Inc. filing 11.8%
  10. CELCBAKER BROS. ADVISORS LP filed Jul 16, 2026 Schedule 13D/A may seek influence 4,877,963 shares issuer: Celcuity Inc. filing 9.99%
  11. ONCBAKER BROS. ADVISORS LP filed Jun 15, 2026 Schedule 13D/A may seek influence 115,457,154 shares issuer: BeOne Medicines Ltd. filing 8%

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • INCY: grant or award (code A), 2 entries, Sep 30, 2026
  • MDGL: grant or award (code A), 2 entries, Jun 17, 2026
  • ONC: grant or award (code A), 2 entries, Jun 11, 2026
Code A
A grant or award from the company, such as stock given as pay.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.